Rethink Every Rule of Cell and Gene Therapy Cell & Gene Therapy Manufacturing & Commercialization Europe December 5-8, 2022 Beurs Van Berlange, Amsterdam, Netherlands Booth #30 REQUEST A MEETING Azenta Hosts First Cryogenic Considerations for Cell & Gene Therapy Symposium Symposium brings together over 100 participants across 60+ organizations READ THE PRESS RELEASE Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program READ THE PRESS RELEASE New Semi-Automated Handheld Screw Cap Decapper A secure seal for each tube REQUEST A DEMO Rise above uncertainty with your cell and gene therapy candidates LEARN MORE TRENDING NOW NEW Handheld Semi-Automated Screw Cap Decapper A secure seal for each tube REQUEST A DEMO SOLUTIONS Protein Biomarker Detection with Olink Proteomics Enables detection and quantification of circulating proteins for an in-depth, biological understanding of disease and drug response. READ MORE EBOOK A Practical Guide to Planning a Cryogenic Storage Facility A comprehensive guide to help you get started DOWNLOAD FEATURED PROMOTIONS Limited-time offers on Azenta solutions Explore exclusive promotions on a variety of Azenta sample exploration and management solutions. VIEW OFFERS ON THE BLOG A Beginner's Guide to Artificial DNA Synthesis: Learn the basics of synthetic DNA and gene synthesis Artificial DNA synthesis, a fundamental tool of synthetic biology, enables scientists to create DNA molecules of virtually any sequence without a template. Construction begins with the base-by-base synthesis of oligos, followed by assembly into double-stranded DNA fragments. These custom DNA fragments can be used directly, cloned into vectors, or assembled into larger constructs to serve a variety of research uses. READ MORE How Olink Technology is Revolutionizing Proteomics and Multiomics The development of scalable and sensitive technologies, such as NGS and qPCR, has revolutionized genomics by enabling nucleic acids of almost any sequence to be amplified and quantified with relative ease using standard chemistries. Proteins, on the other hand, are not as amenable to analysis. Learn how Olink Proteomics is helping to close the gap with their platform for measuring hundreds to thousands of proteins in a small sample. READ MORE Working here Think about it. Your talent and skills can enable scientists to uncover new breakthroughs faster, bringing essential therapies to those who need them most. And you’ll get to work with some amazing people. Learn more about working here and explore current opportunities. Learn More CHOOSE YOUR SAMPLE PATHWAY Sample Sourcing Consumables & Instruments Genomics & Analytical Services Storage, Automation, & Logistics Data & Informatics AZENTA NEWS Insights from the Life Sciences Industry News Medical speaks with Andre Kotze from Azenta to learn more about the company’s portfolio, priorities, and future plans. READ MORE Transcending expectations for cell & gene therapy development How efficient sample management can help to work efficiently and bring therapies to market faster. READ MORE Rhinostics and Azenta Life Sciences Partner to Provide Decapping Solutions for RHINOstic® Automated Swab Workflows “We’re excited to partner with Azenta Life Sciences on this game-changing automated workflow, which allows rapid decapping of a full plate of 96 automated swabs in well under one minute,” explained Cheri Walker, Ph.D., President and CEO of Rhinostics. READ MORE Addressing RNA Research Challenges Technology Networks spoke with Dr. Eliza Small, Senior Manager at Azenta Life Sciences to find out about the major challenges facing researchers developing RNA-based therapeutics and how these challenges can be tackled. READ MORE CONTACT US UPCOMING EVENTS